Assen Jablensky - Publications

Affiliations: 
1996-  

203 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Omlor W, Rabe F, Fuchs S, Cecere G, Homan S, Surbeck W, Kallen N, Georgiadis F, Spiller T, Seifritz E, Weickert T, Bruggemann J, Weickert C, Potkin S, Hashimoto R, ... ... Jablensky A, et al. Estimating multimodal brain variability in schizophrenia spectrum disorders: A worldwide ENIGMA study. Biorxiv : the Preprint Server For Biology. PMID 37961617 DOI: 10.1101/2023.09.22.559032  0.352
2022 Trubetskoy V, Pardiñas AF, Qi T, Panagiotaropoulou G, Awasthi S, Bigdeli TB, Bryois J, Chen CY, Dennison CA, Hall LS, Lam M, Watanabe K, Frei O, Ge T, Harwood JC, ... ... Jablensky AV, et al. Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature. PMID 35396580 DOI: 10.1038/s41586-022-04434-5  0.33
2021 Knowles EEM, Peralta JM, Almasy L, Nimgaonkar V, McMahon FJ, McIntosh AM, Thomson P, Mathias SR, Gur RC, Curran JE, Raventós H, Contreras J, Jablensky A, Badcock J, Blangero J, et al. Genetic Overlap Profiles of Cognitive Ability in Psychotic and Affective Illnesses: A Multisite Study of Multiplex Pedigrees. Biological Psychiatry. PMID 33975707 DOI: 10.1016/j.biopsych.2021.03.012  0.574
2020 Morgan VA, Waterreus A, Ambrosi T, Badcock JC, Cox K, Watts GF, Shymko G, Velayudhan A, Dragovic M, Jablensky A. Mental health recovery and physical health outcomes in psychotic illness: Longitudinal data from the Western Australian survey of high impact psychosis catchments. The Australian and New Zealand Journal of Psychiatry. 4867420954268. PMID 32921130 DOI: 10.1177/0004867420954268  0.571
2020 Smirnova D, Zhukova S, Izmailova O, Fedotov I, Osadshiy Y, Shustov A, Spikina A, Ubeikon D, Yashikhina A, Petrova N, Badcock J, Morgan V, Jablensky A. Use of the Communication Checklist - Self Report (Cc-Sr) in Schizophrenia: Language Impairments Correlate with Poor Premorbid Social Adjustment. Psychiatria Danubina. 32: 88-92. PMID 32890370  0.584
2020 Thygesen JH, Presman A, Harju-Seppänen J, Irizar H, Jones R, Kuchenbaecker K, Lin K, Alizadeh BZ, Austin-Zimmerman I, Bartels-Velthuis A, Bhat A, Bruggeman R, Cahn W, Calafato S, Crespo-Facorro B, ... ... Jablensky A, et al. Genetic copy number variants, cognition and psychosis: a meta-analysis and a family study. Molecular Psychiatry. PMID 32719466 DOI: 10.1038/S41380-020-0820-7  0.517
2019 Liu X, Low SK, Atkins JR, Wu JQ, Reay WR, Cairns HM, Green MJ, Schall U, Jablensky A, Mowry B, Michie PT, Catts SV, Henskens F, Pantelis C, Loughland C, et al. Wnt receptor gene was associated with schizophrenia in genome-wide SNP analysis of the Australian Schizophrenia Research Bank cohort. The Australian and New Zealand Journal of Psychiatry. 4867419885443. PMID 31735061 DOI: 10.1177/0004867419885443  0.469
2019 Morgan VA, Di Prinzio P, Valuri G, Croft M, McNeil T, Jablensky A. Are familial liability for schizophrenia and obstetric complications independently associated with risk of psychotic illness, after adjusting for other environmental stressors in childhood? The Australian and New Zealand Journal of Psychiatry. 4867419864427. PMID 31339337 DOI: 10.1177/0004867419864427  0.424
2019 Valuri GM, Morgan F, Jablensky A, Ambrosi TL, Morgan VA. Impact of substance use and other risk factor exposures on conviction rates by people with a psychotic illness and other mental disorders. Social Psychiatry and Psychiatric Epidemiology. PMID 31324961 DOI: 10.1007/S00127-019-01751-5  0.342
2019 Morgan VA, Badcock JC, Di Prinzio P, Ambrosi T, Clark M, Valuri G, Jablensky A. Invited response to commentary. Small numbers are not predictive: Congenital blindness may or may not be protective for schizophrenia. Schizophrenia Research. PMID 31088702 DOI: 10.1016/J.Schres.2019.05.003  0.641
2019 Reed GM, First MB, Kogan CS, Hyman SE, Gureje O, Gaebel W, Maj M, Stein DJ, Maercker A, Tyrer P, Claudino A, Garralda E, Salvador-Carulla L, Ray R, Saunders JB, ... ... Jablensky A, et al. Innovations and changes in the ICD-11 classification of mental, behavioural and neurodevelopmental disorders. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 18: 3-19. PMID 30600616 DOI: 10.1002/Wps.20611  0.33
2019 McCarthy N, Laws SM, Porter T, Burnham SC, Moses EK, Jablensky A. INCREASED PREDICTED C4A EXPRESSION IS ASSOCIATED WITH COGNITIVE DEFICIT IN BOTH SCHIZOPHRENIA AND ALZHEIMER'S DISEASE European Neuropsychopharmacology. 29: S871. DOI: 10.1016/J.Euroneuro.2017.08.163  0.429
2018 McCarthy NS, Clark ML, Jablensky A, Badcock JC. No association between common genetic variation in FOXP2 and language impairment in schizophrenia. Psychiatry Research. 271: 590-597. PMID 30554107 DOI: 10.1016/J.Psychres.2018.12.016  0.628
2018 Morgan VA, Clark M, Crewe J, Valuri G, Mackey DA, Badcock JC, Jablensky A. Congenital blindness is protective for schizophrenia and other psychotic illness. A whole-population study. Schizophrenia Research. 202: 414-416. PMID 30539775 DOI: 10.1016/J.Schres.2018.06.061  0.675
2018 Di Prinzio P, Morgan VA, Björk J, Croft M, Lin A, Jablensky A, McNeil TF. Intellectual Disability and Psychotic Disorders in Children: Association With Maternal Severe Mental Illness and Exposure to Obstetric Complications in a Whole-Population Cohort. The American Journal of Psychiatry. appiajp201817101153. PMID 30278792 DOI: 10.1176/Appi.Ajp.2018.17101153  0.308
2018 Calafato MS, Thygesen JH, Ranlund S, Zartaloudi E, Cahn W, Crespo-Facorro B, Díez-Revuelta Á, Di Forti M, Hall MH, Iyegbe C, Jablensky A, Kahn R, Kalaydjieva L, Kravariti E, et al. Use of schizophrenia and bipolar disorder polygenic risk scores to identify psychotic disorders. The British Journal of Psychiatry : the Journal of Mental Science. 213: 535-541. PMID 30113282 DOI: 10.1192/Bjp.2018.89  0.471
2018 van Erp TGM, Walton E, Hibar DP, Schmaal L, Jiang W, Glahn DC, Pearlson GD, Yao N, Fukunaga M, Hashimoto R, Okada N, Yamamori H, Bustillo JR, Clark VP, Agartz I, ... ... Jablensky A, et al. Cortical Brain Abnormalities in 4474 Individuals With Schizophrenia and 5098 Control Subjects via the Enhancing Neuro Imaging Genetics Through Meta Analysis (ENIGMA) Consortium. Biological Psychiatry. PMID 29960671 DOI: 10.1016/j.biopsych.2018.04.023  0.329
2018 Glahn DC, Nimgaonkar VL, Raventós H, Contreras J, McIntosh AM, Thomson PA, Jablensky A, McCarthy NS, Charlesworth JC, Blackburn NB, Peralta JM, Knowles EEM, Mathias SR, Ament SA, McMahon FJ, et al. Rediscovering the value of families for psychiatric genetics research. Molecular Psychiatry. PMID 29955165 DOI: 10.1038/S41380-018-0073-X  0.342
2018 Waterreus A, Di Prinzio P, Badcock JC, Martin-Iverson M, Jablensky A, Morgan VA. Is cannabis a risk factor for suicide attempts in men and women with psychotic illness? Psychopharmacology. PMID 29766209 DOI: 10.1007/S00213-018-4924-6  0.568
2018 Fonseca-Pedrero E, Ortuño J, Debbané M, Chan RCK, Cicero D, Zhang LC, Brenner C, Barkus E, Linscott RJ, Kwapil T, Barrantes-Vidal N, Cohen A, Raine A, Compton MT, Tone EB, ... ... Jablensky A, et al. The Network Structure of Schizotypal Personality Traits. Schizophrenia Bulletin. PMID 29684178 DOI: 10.1093/Schbul/Sby044  0.542
2018 Fonseca-Pedrero E, Chan RCK, Debbané M, Cicero D, Zhang LC, Brenner C, Barkus E, Linscott RJ, Kwapil T, Barrantes-Vidal N, Cohen A, Raine A, Compton MT, Tone EB, Suhr J, ... ... Jablensky A, et al. Comparisons of schizotypal traits across 12 countries: Results from the International Consortium for Schizotypy Research. Schizophrenia Research. PMID 29567403 DOI: 10.1016/J.Schres.2018.03.021  0.582
2018 Khan FF, Melton PE, McCarthy NS, Morar B, Blangero J, Moses EK, Jablensky A. Whole genome sequencing of 91 multiplex schizophrenia families reveals increased burden of rare, exonic copy number variation in schizophrenia probands and genetic heterogeneity. Schizophrenia Research. PMID 29486958 DOI: 10.1016/J.Schres.2018.02.034  0.46
2018 Smirnova DA, Petrova NN, Pavlichenko AV, Martynikhin IA, Dorofeikova MV, Eremkin VI, Izmailova OV, Osadshiy YY, Romanov DV, Ubeikon DA, Fedotov IA, Sheifer MS, Shustov AD, Yashikhina AA, Clark M, ... ... Jablensky A, et al. [Multi-centre clinical assessment of the Russian language version of the Diagnostic Interview for Psychoses]. Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova. 118: 50-60. PMID 29460905 DOI: 10.17116/Jnevro20181181150-60  0.548
2018 Waterreus A, Prinzio PD, Badcock J, Martin-Iverson M, Jablensky A, Morgan V. S103. IS CANNABIS A RISK FACTOR FOR SUICIDE ATTEMPTS IN MEN AND WOMEN WITH PSYCHOTIC ILLNESS? Schizophrenia Bulletin. 44: S365-S365. DOI: 10.1093/Schbul/Sby018.890  0.569
2018 Galletly C, Castle D, Dark F, Humberstone V, Jablensky A, Killackey E, Kulkarni J, McGorry P, Nielssen O, Tran N. T249. The Royal Australian And New Zealand Clinical Practice Guidelines For Schizophrenia And Related Disorders (2016) – A Step Towards Better Care? Schizophrenia Bulletin. 44. DOI: 10.1093/Schbul/Sby016.525  0.397
2017 Fonseca-Pedrero E, Ortuño-Sierra J, Lucas-Molina B, Debbané M, Chan RCK, Cicero DC, Zhang LC, Brenner C, Barkus E, Linscott RJ, Kwapil T, Barrantes-Vidal N, Cohen A, Raine A, Compton MT, ... ... Jablensky A, et al. Brief assessment of schizotypal traits: A multinational study. Schizophrenia Research. PMID 29113776 DOI: 10.1016/J.Schres.2017.10.043  0.581
2017 Blakey R, Ranlund S, Zartaloudi E, Cahn W, Calafato S, Colizzi M, Crespo-Facorro B, Daniel C, Díez-Revuelta Á, Di Forti M, Iyegbe C, Jablensky A, Jones R, Hall MH, et al. Associations between psychosis endophenotypes across brain functional, structural, and cognitive domains. Psychological Medicine. 1-20. PMID 29094675 DOI: 10.1017/S0033291717002860  0.322
2017 McCarthy NS, Badcock JC, Clark ML, Knowles EEM, Cadby G, Melton PE, Morgan VA, Blangero J, Moses EK, Glahn DC, Jablensky A. Assessment of Cognition and Personality as Potential Endophenotypes in the Western Australian Family Study of Schizophrenia. Schizophrenia Bulletin. PMID 29040798 DOI: 10.1093/Schbul/Sbx141  0.662
2017 Kelly S, Jahanshad N, Zalesky A, Kochunov P, Agartz I, Alloza C, Andreassen OA, Arango C, Banaj N, Bouix S, Bousman CA, Brouwer RM, Bruggemann J, Bustillo J, Cahn W, ... ... Jablensky A, et al. Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA Schizophrenia DTI Working Group. Molecular Psychiatry. PMID 29038599 DOI: 10.1038/Mp.2017.170  0.47
2017 Jablensky A, McNeil TF, Morgan VA. Barbara Fish and a Short History of the Neurodevelopmental Hypothesis of Schizophrenia. Schizophrenia Bulletin. PMID 29036635 DOI: 10.1093/Schbul/Sbx094  0.485
2017 Castle DJ, Galletly CA, Dark F, Humberstone V, Morgan VA, Killackey E, Kulkarni J, McGorry P, Nielssen O, Tran NT, Jablensky A. The 2016 Royal Australian and New Zealand College of Psychiatrists guidelines for the management of schizophrenia and related disorders. The Medical Journal of Australia. 206: 501-505. PMID 28918734 DOI: 10.5694/Mja16.01159  0.379
2017 Jablensky A, Castle DJ, Dark F, Humberstone V, Killackey E, Kulkarni J, McGorry P, Morgan VA, Nielssen O, Tran N, Galletly C. The 2016 RANZCP Guidelines for the Management of Schizophrenia and Related Disorders - what's next? Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists. 1039856217726691. PMID 28875719 DOI: 10.1177/1039856217726691  0.436
2017 Ranlund S, Calafato S, Thygesen JH, Lin K, Cahn W, Crespo-Facorro B, de Zwarte SMC, Díez Á, Di Forti M, Iyegbe C, Jablensky A, Jones R, Hall MH, Kahn R, et al. A polygenic risk score analysis of psychosis endophenotypes across brain functional, structural, and cognitive domains. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. PMID 28851104 DOI: 10.1002/Ajmg.B.32581  0.487
2017 Smirnova D, Clark M, Jablensky A, Badcock JC. Action (verb) fluency deficits in schizophrenia spectrum disorders: linking language, cognition and interpersonal functioning. Psychiatry Research. 257: 203-211. PMID 28772137 DOI: 10.1016/J.Psychres.2017.07.044  0.668
2017 Fonseca-Pedrero E, Debbané M, Ortuño-Sierra J, Chan RCK, Cicero DC, Zhang LC, Brenner C, Barkus E, Linscott RJ, Kwapil T, Barrantes-Vidal N, Cohen A, Raine A, Compton MT, Tone EB, ... ... Jablensky A, et al. The structure of schizotypal personality traits: a cross-national study. Psychological Medicine. 1-12. PMID 28712364 DOI: 10.1017/S0033291717001829  0.554
2017 Morar B, Badcock JC, Phillips M, Almeida OP, Jablensky A. The longevity gene Klotho is differentially associated with cognition in subtypes of schizophrenia. Schizophrenia Research. PMID 28673754 DOI: 10.1016/J.Schres.2017.06.054  0.644
2017 Jablensky A. Commentary on McGorry PD (2017), Back to the future: Schizophrenia in retrospect and prospect. The Australian and New Zealand Journal of Psychiatry. 4867417715916. PMID 28656777 DOI: 10.1177/0004867417715916  0.385
2017 Clark ML, Waters F, Vatskalis TM, Jablensky A. On the interconnectedness and prognostic value of visual and auditory hallucinations in first-episode psychosis. European Psychiatry : the Journal of the Association of European Psychiatrists. 41: 122-128. PMID 28142106 DOI: 10.1016/J.Eurpsy.2016.10.011  0.353
2017 Morgan V, Prinzio PD, Valuri G, Croft M, Shah S, McNeil T, Jablensky A. 36. Are Familial Liability and Obstetric Complications Independently Associated With Risk of a Psychotic ILLNESS, After Adjusting for Other Environmental STRESSORS? Schizophrenia Bulletin. 43: S21-S21. DOI: 10.1093/Schbul/Sbx021.055  0.303
2017 McCarthy N, Clark M, Cadby G, Blangero J, Dragovic M, Melton P, Moses E, Badcock J, Jablensky A. Association Between Polygenic Risk Score for Schizophrenia and Neurocognitive Measures in the Western Australian Family Study of Schizophrenia (Wafss) European Neuropsychopharmacology. 27: S505-S506. DOI: 10.1016/J.Euroneuro.2016.09.611  0.619
2016 McCarthy NS, Melton PE, Ward SV, Allan SM, Dragovic M, Clark ML, Morar B, Rubio JP, Blangero J, Badcock JC, Morgan VA, Moses EK, Jablensky A. Exome array analysis suggests an increased variant burden in families with schizophrenia. Schizophrenia Research. PMID 27939555 DOI: 10.1016/J.Schres.2016.12.007  0.662
2016 Morgan VA, Waterreus A, Carr V, Castle D, Cohen M, Harvey C, Galletly C, Mackinnon A, McGorry P, McGrath JJ, Neil AL, Saw S, Badcock JC, Foley DL, Waghorn G, ... ... Jablensky A, et al. Responding to challenges for people with psychotic illness: Updated evidence from the Survey of High Impact Psychosis. The Australian and New Zealand Journal of Psychiatry. PMID 27913580 DOI: 10.1177/0004867416679738  0.603
2016 Lin A, Di Prinzio P, Young D, Jacoby P, Whitehouse A, Waters F, Jablensky A, Morgan VA. Academic Performance in Children of Mothers With Schizophrenia and Other Severe Mental Illness, and Risk for Subsequent Development of Psychosis: A Population-Based Study. Schizophrenia Bulletin. PMID 27131155 DOI: 10.1093/Schbul/Sbw042  0.44
2016 Galletly C, Castle D, Dark F, Humberstone V, Jablensky A, Killackey E, Kulkarni J, McGorry P, Nielssen O, Tran N. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders. The Australian and New Zealand Journal of Psychiatry. 50: 410-72. PMID 27106681 DOI: 10.1177/0004867416641195  0.454
2016 Jablensky A. Psychiatric classifications: validity and utility. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 15: 26-31. PMID 26833601 DOI: 10.1002/Wps.20284  0.336
2015 Morgan VA, Morgan F, Galletly C, Valuri G, Shah S, Jablensky A. Sociodemographic, clinical and childhood correlates of adult violent victimisation in a large, national survey sample of people with psychotic disorders. Social Psychiatry and Psychiatric Epidemiology. PMID 26581211 DOI: 10.1007/S00127-015-1155-6  0.308
2015 Badcock JC, Shah S, Mackinnon A, Stain HJ, Galletly C, Jablensky A, Morgan VA. Loneliness in psychotic disorders and its association with cognitive function and symptom profile. Schizophrenia Research. PMID 26527247 DOI: 10.1016/J.Schres.2015.10.027  0.616
2015 Power BD, Dragovic M, Badcock JC, Morgan VA, Castle D, Jablensky A, Stefanis NC. No additive effect of cannabis on cognition in schizophrenia. Schizophrenia Research. 168: 245-51. PMID 26235754 DOI: 10.1016/J.Schres.2015.06.026  0.657
2015 Badcock JC, Clark ML, Pedruzzi RA, Morgan VA, Jablensky A. Intact speed of processing in a community-based sample of adults with high schizotypy: A marker of reduced psychosis risk? Psychiatry Research. PMID 26117248 DOI: 10.1016/J.Psychres.2015.06.003  0.638
2015 Jablensky A. Schizophrenia or schizophrenias? The challenge of genetic parsing of a complex disorder. The American Journal of Psychiatry. 172: 105-7. PMID 25640926 DOI: 10.1176/Appi.Ajp.2014.14111452  0.497
2015 Power BD, Dragovic M, Badcock JC, Morgan VA, Castle D, Jablensky A, Stefanis NC. No additive effect of cannabis on cognition in schizophrenia Schizophrenia Research. DOI: 10.1016/j.schres.2015.06.026  0.637
2014 Jiang Z, Du C, Jablensky A, Liang H, Lu Z, Ma Y, Teo KL. Analysis of schizophrenia data using a nonlinear threshold index logistic model. Plos One. 9: e109454. PMID 25330160 DOI: 10.1371/Journal.Pone.0109454  0.405
2014 Graham KT, Martin-Iverson MT, Holmes NP, Jablensky A, Waters F. Deficits in agency in schizophrenia, and additional deficits in body image, body schema, and internal timing, in passivity symptoms. Frontiers in Psychiatry. 5: 126. PMID 25309460 DOI: 10.3389/Fpsyt.2014.00126  0.41
2014 Stefanis NC, Dragovic M, Power BD, Jablensky A, Castle D, Morgan VA. The effect of drug use on the age at onset of psychotic disorders in an Australian cohort. Schizophrenia Research. 156: 211-6. PMID 24831390 DOI: 10.1016/J.Schres.2014.04.003  0.327
2014 Morgan VA, McGrath JJ, Jablensky A, Badcock JC, Waterreus A, Bush R, Carr V, Castle D, Cohen M, Galletly C, Harvey C, Hocking B, McGorry P, Neil AL, Saw S, et al. Psychosis prevalence and physical, metabolic and cognitive co-morbidity: data from the second Australian national survey of psychosis. Psychological Medicine. 44: 2163-76. PMID 24365456 DOI: 10.1017/S0033291713002973  0.615
2014 Power BD, Stefanis NC, Dragovic M, Jablensky A, Castle D, Morgan V. Age at initiation of amphetamine use and age at onset of psychosis: the Australian Survey of High Impact Psychosis. Schizophrenia Research. 152: 300-2. PMID 24275582 DOI: 10.1016/J.Schres.2013.11.003  0.323
2014 Bramon E, Pirinen M, Strange A, Lin K, Freeman C, Bellenguez C, Su Z, Band G, Pearson R, Vukcevic D, Langford C, Deloukas P, Hunt S, ... ... Jablensky A, et al. A genome-wide association analysis of a broad psychosis phenotype identifies three loci for further investigation. Biological Psychiatry. 75: 386-97. PMID 23871474 DOI: 10.1016/J.Biopsych.2013.03.033  0.483
2014 Steinberg S, de Jong S, Mattheisen M, Costas J, Demontis D, Jamain S, Pietiläinen OP, Lin K, Papiol S, Huttenlocher J, Sigurdsson E, Vassos E, Giegling I, Breuer R, Fraser G, ... ... Jablensky A, et al. Common variant at 16p11.2 conferring risk of psychosis. Molecular Psychiatry. 19: 108-14. PMID 23164818 DOI: 10.1038/Mp.2012.157  0.448
2014 Morgan VA, Valuri G, Croft M, Shah S, Di Prinzio P, Griffith J, McNeil T, Jablensky AV. Longitudinal, Whole-population Data Examining Pathways of Risk from Conception to Disease: The Western Australian Schizophrenia High-risk e-Cohort Open Health Data. 2. DOI: 10.5334/Ohd.Aj  0.419
2013 Jablensky A. Schizophrenia in DSM-5: assets and liabilities. Schizophrenia Research. 150: 36-7. PMID 24025695 DOI: 10.1016/J.Schres.2013.07.037  0.451
2013 Ripke S, O'Dushlaine C, Chambert K, Moran JL, Kähler AK, Akterin S, Bergen SE, Collins AL, Crowley JJ, Fromer M, Kim Y, Lee SH, Magnusson PK, Sanchez N, Stahl EA, ... ... Jablensky A, et al. Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nature Genetics. 45: 1150-9. PMID 23974872 DOI: 10.1038/Ng.2742  0.382
2013 Stefanis NC, Dragovic M, Power BD, Jablensky A, Castle D, Morgan VA. Age at initiation of cannabis use predicts age at onset of psychosis: the 7- to 8-year trend. Schizophrenia Bulletin. 39: 251-4. PMID 23314189 DOI: 10.1093/Schbul/Sbs188  0.333
2013 Morgan VA, Morgan F, Valuri G, Ferrante A, Castle D, Jablensky A. A whole-of-population study of the prevalence and patterns of criminal offending in people with schizophrenia and other mental illness. Psychological Medicine. 43: 1869-80. PMID 23234722 DOI: 10.1017/S0033291712002887  0.487
2013 Power BD, Dragovic M, Jablensky A, Stefanis NC. Does accumulating exposure to illicit drugs bring forward the age at onset in schizophrenia? The Australian and New Zealand Journal of Psychiatry. 47: 51-8. PMID 23042939 DOI: 10.1177/0004867412461957  0.353
2013 Green MJ, Cairns MJ, Wu J, Dragovic M, Jablensky A, Tooney PA, Scott RJ, Carr VJ. Genome-wide supported variant MIR137 and severe negative symptoms predict membership of an impaired cognitive subtype of schizophrenia. Molecular Psychiatry. 18: 774-80. PMID 22733126 DOI: 10.1038/Mp.2012.84  0.428
2013 Morgan V, Morgan F, Valuri G, Ferrante A, Castle D, Jablensky A. Erratum: A whole-of-population study of the prevalence and patterns of criminal offending in people with schizophrenia and other mental illness (Psychological Medicine (2013) 43(09) (1869–1880) (10.1017/S0033291712002887)) Psychological Medicine. 43. DOI: 10.1017/S0033291713001463  0.434
2012 Morgan VA, Waterreus A, Jablensky A, Mackinnon A, McGrath JJ, Carr V, Bush R, Castle D, Cohen M, Harvey C, Galletly C, Stain HJ, Neil AL, McGorry P, Hocking B, et al. People living with psychotic illness in 2010: the second Australian national survey of psychosis. The Australian and New Zealand Journal of Psychiatry. 46: 735-52. PMID 22696547 DOI: 10.1177/0004867412449877  0.383
2012 Waterreus A, Morgan VA, Castle D, Galletly C, Jablensky A, Di Prinzio P, Shah S. Medication for psychosis--consumption and consequences: the second Australian national survey of psychosis. The Australian and New Zealand Journal of Psychiatry. 46: 762-73. PMID 22689337 DOI: 10.1177/0004867412450471  0.344
2012 Ayoub MA, Angelicheva D, Vile D, Chandler D, Morar B, Cavanaugh JA, Visscher PM, Jablensky A, Pfleger KD, Kalaydjieva L. Deleterious GRM1 mutations in schizophrenia. Plos One. 7: e32849. PMID 22448230 DOI: 10.1371/Journal.Pone.0032849  0.439
2012 Verbrugghe P, Bouwer S, Wiltshire S, Carter K, Chandler D, Cooper M, Morar B, Razif MF, Henders A, Badcock JC, Dragovic M, Carr V, Almeida OP, Flicker L, Montgomery G, ... Jablensky A, et al. Impact of the Reelin signaling cascade (ligands-receptors-adaptor complex) on cognition in schizophrenia. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 159: 392-404. PMID 22419519 DOI: 10.1002/Ajmg.B.32042  0.676
2012 Jablensky A. Prototypes, syndromes and dimensions of psychopathology: an open agenda for research. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 11: 22-3. PMID 22294999 DOI: 10.1016/J.Wpsyc.2012.01.020  0.383
2012 Jablensky A, Angelicheva D, Donohoe GJ, Cruickshank M, Azmanov DN, Morris DW, McRae A, Weickert CS, Carter KW, Chandler D, Alexandrov B, Usheva A, Morar B, Verbrugghe PL, Filipovska A, et al. Promoter polymorphisms in two overlapping 6p25 genes implicate mitochondrial proteins in cognitive deficit in schizophrenia. Molecular Psychiatry. 17: 1328-39. PMID 21968932 DOI: 10.1038/Mp.2011.129  0.595
2012 Catts VS, Catts SV, Jablensky A, Chandler D, Weickert CS, Lavin MF. Evidence of aberrant DNA damage response signalling but normal rates of DNA repair in dividing lymphoblasts from patients with schizophrenia. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 13: 114-25. PMID 21830993 DOI: 10.3109/15622975.2011.565073  0.382
2012 Henskens F, Paul D, Loughland C, Bridge J, McCabe K, Catts S, Jablensky A, Michie P, Mowry B, Pantelis C, Schal U, Tooney P, Duffy L, Carr V. Poster #178 THE AUSTRALIAN SCHIZOPHRENIA RESEARCH BIOBANK (ASRB): IT DEVELOPMENT AND MANAGEMENT OF A LIVE E-RESEARCH SYSTEM Schizophrenia Research. 136. DOI: 10.1016/S0920-9964(12)70750-8  0.381
2012 Loughland CM, McCabe K, Bridge J, Henskens F, Catts S, Jablensky A, Michie P, Mowry B, Pantelis C, Schall U, Scott R, Tooney P, Duffy L, Carr V. Poster #177 THE AUSTRALIAN SCHIZOPHRENIA RESEARCH BIOBANK (ASRB): AN AUDIT OF THE FIRST FIVE-YEARS OF RECRUITMENT RESOURCE ACCESS Schizophrenia Research. 136. DOI: 10.1016/S0920-9964(12)70749-1  0.441
2012 Green MI, Cairns MJ, Wu JQ, Dragovic M, Jablensky A, Tooney P, Scott R, Carr VJ. Poster #114 GENOME-WIDE SUPPORTED VARIANTS (MIR137) PREDICTS MEMBERSHIP OF A COGNITIVE SUBTYPE OF SCHIZOPHRENIA Schizophrenia Research. 136. DOI: 10.1016/S0920-9964(12)70686-2  0.384
2011 Mazhari S, Price G, Dragović M, Waters FA, Clissa P, Jablensky A. Revisiting the suitability of antisaccade performance as an endophenotype in schizophrenia. Brain and Cognition. 77: 223-30. PMID 21924537 DOI: 10.1016/J.Bandc.2011.08.006  0.424
2011 Fullston T, Gabb B, Callen D, Ullmann R, Woollatt E, Bain S, Ropers HH, Cooper M, Chandler D, Carter K, Jablensky A, Kalaydjieva L, Gecz J. Inherited balanced translocation t(9;17)(q33.2;q25.3) concomitant with a 16p13.1 duplication in a patient with schizophrenia. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 156: 204-14. PMID 21302349 DOI: 10.1002/Ajmg.B.31157  0.386
2011 Mazhari S, Price G, Waters F, Dragović M, Jablensky A. Evidence of abnormalities in mid-latency auditory evoked responses (MLAER) in cognitive subtypes of patients with schizophrenia. Psychiatry Research. 187: 317-23. PMID 21292328 DOI: 10.1016/J.Psychres.2011.01.003  0.459
2011 Jablensky A, Morar B, Wiltshire S, Carter K, Dragovic M, Badcock JC, Chandler D, Peters K, Kalaydjieva L. Polymorphisms associated with normal memory variation also affect memory impairment in schizophrenia. Genes, Brain, and Behavior. 10: 410-7. PMID 21281445 DOI: 10.1111/J.1601-183X.2011.00679.X  0.665
2011 Waters F, Sinclair C, Rock D, Jablensky A, Foster RG, Wulff K. Daily variations in sleep-wake patterns and severity of psychopathology: a pilot study in community-dwelling individuals with chronic schizophrenia. Psychiatry Research. 187: 304-6. PMID 21272939 DOI: 10.1016/J.Psychres.2011.01.006  0.345
2011 Waters F, Rock D, Dragovic M, Jablensky A. 'Social dysmetria' in first-episode psychosis patients. Acta Psychiatrica Scandinavica. 123: 475-84. PMID 21166784 DOI: 10.1111/J.1600-0447.2010.01651.X  0.346
2011 Badcock JC, Dragović M, Garrett C, Jablensky A. Action (verb) fluency in schizophrenia: getting a grip on odd speech. Schizophrenia Research. 126: 138-43. PMID 21109405 DOI: 10.1016/J.Schres.2010.11.004  0.651
2011 Kendler KS, Jablensky A. Kraepelin's concept of psychiatric illness. Psychological Medicine. 41: 1119-26. PMID 20809997 DOI: 10.1017/S0033291710001509  0.372
2011 Morar B, Dragović M, Waters FA, Chandler D, Kalaydjieva L, Jablensky A. Neuregulin 3 (NRG3) as a susceptibility gene in a schizophrenia subtype with florid delusions and relatively spared cognition. Molecular Psychiatry. 16: 860-6. PMID 20548296 DOI: 10.1038/Mp.2010.70  0.447
2011 Hyman SE, Andrews G, Ayuso-Mateos JL, Gaebel W, Goldberg DP, Gureje O, Jablensky A, Khoury B, Lovell A, Medina Mora ME, Rahimi-Movaghar A, Ritchie K, Saeed K, Sartorius N, Sharan P, et al. A conceptual framework for the revision of the ICD-10 classification of mental and behavioural disorders World Psychiatry. 10: 86-92. DOI: 10.1002/J.2051-5545.2011.Tb00022.X  0.307
2011 Jablensky A, Kirkbride JB, Jones PB. Schizophrenia: The Epidemiological Horizon Schizophrenia: Third Edition. 185-225. DOI: 10.1002/9781444327298.ch10  0.38
2010 Loughland C, Draganic D, McCabe K, Richards J, Nasir A, Allen J, Catts S, Jablensky A, Henskens F, Michie P, Mowry B, Pantelis C, Schall U, Scott R, Tooney P, et al. Australian Schizophrenia Research Bank: a database of comprehensive clinical, endophenotypic and genetic data for aetiological studies of schizophrenia. The Australian and New Zealand Journal of Psychiatry. 44: 1029-35. PMID 21034186 DOI: 10.3109/00048674.2010.501758  0.492
2010 Jablensky A. The diagnostic concept of schizophrenia: its history, evolution, and future prospects. Dialogues in Clinical Neuroscience. 12: 271-87. PMID 20954425  0.415
2010 Walters JT, Corvin A, Owen MJ, Williams H, Dragovic M, Quinn EM, Judge R, Smith DJ, Norton N, Giegling I, Hartmann AM, Möller HJ, Muglia P, Moskvina V, Dwyer S, ... ... Jablensky A, et al. Psychosis susceptibility gene ZNF804A and cognitive performance in schizophrenia. Archives of General Psychiatry. 67: 692-700. PMID 20603450 DOI: 10.1001/Archgenpsychiatry.2010.81  0.447
2010 Mazhari S, Badcock JC, Waters FA, Dragovi? M, Badcock DR, Jablensky A. Impaired spatial working memory maintenance in schizophrenia involves both spatial coordinates and spatial reference frames. Psychiatry Research. 179: 253-8. PMID 20493553 DOI: 10.1016/J.Psychres.2009.09.002  0.648
2010 Rossi A, Morgan V, Amaddeo F, Sandri M, Grigoletti L, Maggioni F, Ferro A, Rigon E, Donisi V, Venturi VV, Goria F, Skre I, Tansella M, Jablensky A. Diagnosing psychotic disorders: validity, reliability and applications of the Diagnostic Interview for Psychosis (DIP). Italian version. Epidemiologia E Psichiatria Sociale. 19: 33-43. PMID 20486422 DOI: 10.1017/S1121189X00001585  0.317
2010 Jablensky A. Psychiatry in crisis? Back to fundamentals. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 9: 29. PMID 20148150 DOI: 10.1002/J.2051-5545.2010.Tb00258.X  0.328
2010 Chandler D, Dragović M, Cooper M, Badcock JC, Mullin BH, Faulkner D, Wilson SG, Hallmayer J, Howell S, Rock D, Palmer LJ, Kalaydjieva L, Jablensky A. Impact of Neuritin 1 (NRN1) polymorphisms on fluid intelligence in schizophrenia. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 153: 428-37. PMID 19569075 DOI: 10.1002/Ajmg.B.30996  0.611
2010 Carr V, Loughland C, McCabe K, Nasir A, Catts S, Jablensky A, Henskens F, Michie P, Mowry B, Pantelis C, Schall U, Tooney P, Scott R. The Australian Schizophrenia Research Bank (ASRB): Demographic, clinical and neuropsychological profile of participants with schizophrenia Australian and New Zealand Journal of Psychiatry. 44. DOI: 10.3109/00048674.2010.507066  0.481
2010 Henskens F, Carr V, Catts S, Jablensky A, Michie P, Loughland C, McCabe K, Mowry B, Nasir A, Pantelis C, Rasser P, Paul D, Richards J, Schall U, Scott R. THE AUSTRALIAN SCHIZOPHRENIA RESEARCH BANK (ASRB): AN EXAMPLE OF ERESEARCH Schizophrenia Research. 117: 427-428. DOI: 10.1016/J.Schres.2010.02.788  0.456
2010 Carr V, Loughland C, McCabe K, Nasir A, Stan C, Jablensky A, Henskens F, Michie P, Mowry B, Pantelis C, Schall U, Scott R. The Australian Schizophrenia Research Bank (Asrb): Demographic, Clinical And Neuropsychological Profiles For The First 500 Participants With Schizophrenia Schizophrenia Research. 117: 312-312. DOI: 10.1016/J.Schres.2010.02.525  0.481
2010 McCabe KL, Loughland CM, Nasir A, Catts S, Jablensky A, Henskens F, Michie P, Mowry B, Pantelis C, Schall U, Scott R, Carr V. The Australian Schizophrenia Research Bank (Asrb): Quality Assurance And Control For A Comprehensive Clinical, Neuropsychological, Genetic And Neuroimaging Database For Researchers Schizophrenia Research. 117: 200-200. DOI: 10.1016/J.Schres.2010.02.269  0.317
2009 Waters F, Price G, Dragović M, Jablensky A. Electrophysiological brain activity and antisaccade performance in schizophrenia patients with first-rank (passivity) symptoms. Psychiatry Research. 170: 140-9. PMID 19906434 DOI: 10.1016/J.Psychres.2008.10.033  0.399
2009 Stober G, Ben-Shachar D, Cardon M, Falkai P, Fonteh AN, Gawlik M, Glenthoj BY, Grunblatt E, Jablensky A, Kim YK, Kornhuber J, McNeil TF, Muller N, Oranje B, Saito T, et al. Schizophrenia: from the brain to peripheral markers. A consensus paper of the WFSBP task force on biological markers. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 10: 127-55. PMID 19396704 DOI: 10.1080/15622970902898980  0.42
2009 Waters F, Jablensky A. Time discrimination deficits in schizophrenia patients with first-rank (passivity) symptoms. Psychiatry Research. 167: 12-20. PMID 19339057 DOI: 10.1016/J.Psychres.2008.04.004  0.45
2009 Waters FA, Badcock JC, Dragović M, Jablensky A. Neuropsychological functioning in schizophrenia patients with first-rank (passivity) symptoms. Psychopathology. 42: 47-58. PMID 19127100 DOI: 10.1159/000187634  0.617
2009 Henskens FA, Loughland CM, Aphale MS, Paul D, Richards JM, Rasser P, Carr VJ, Catts SV, Jablensky A, Michie PT, Mowry BJ, Pantelis C. it support for the australian schizophrenia research bank Healthinf 2009 - Proceedings of the 2nd International Conference On Health Informatics. 405-410.  0.348
2008 Hauck Y, Rock D, Jackiewicz T, Jablensky A. Healthy babies for mothers with serious mental illness: a case management framework for mental health clinicians. International Journal of Mental Health Nursing. 17: 383-91. PMID 19128285 DOI: 10.1111/J.1447-0349.2008.00573.X  0.321
2008 Morgan VA, Leonard H, Bourke J, Jablensky A. Intellectual disability co-occurring with schizophrenia and other psychiatric illness: population-based study. The British Journal of Psychiatry : the Journal of Mental Science. 193: 364-72. PMID 18978313 DOI: 10.1192/Bjp.Bp.107.044461  0.458
2008 Dragovic M, Waters FA, Jablensky A. Estimating premorbid intelligence in schizophrenia patients: demographically based approach. The Australian and New Zealand Journal of Psychiatry. 42: 814-8. PMID 18696286 DOI: 10.1080/00048670802277214  0.398
2008 Peters K, Wiltshire S, Henders AK, Dragović M, Badcock JC, Chandler D, Howell S, Ellis C, Bouwer S, Montgomery GW, Palmer LJ, Kalaydjieva L, Jablensky A. Comprehensive analysis of tagging sequence variants in DTNBP1 shows no association with schizophrenia or with its composite neurocognitive endophenotypes. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 147: 1159-66. PMID 18314870 DOI: 10.1002/Ajmg.B.30741  0.688
2008 Jablensky A, Sartorius N. What did the WHO studies really find? Schizophrenia Bulletin. 34: 253-5. PMID 18203759 DOI: 10.1093/Schbul/Sbm151  0.393
2008 Badcock JC, Badcock DR, Read C, Jablensky A. Examining encoding imprecision in spatial working memory in schizophrenia. Schizophrenia Research. 100: 144-52. PMID 17804202 DOI: 10.1016/J.Schres.2007.08.005  0.638
2008 Valuri G, Croft M, Morgan V, Jablensky A. THE HIGH RISK CHILDREN OF MOTHERS WITH SCHIZOPHRENIA AND OTHER SEVERE MENTAL ILLNESS: MODELLING RISK FROM CONCEPTION TO DISEASE Schizophrenia Research. 102: 169. DOI: 10.1016/S0920-9964(08)70516-4  0.393
2008 Morgan V, Zubrick S, Bower C, Croft M, Valuri G, Griffith J, Jablensky A. WHAT IMPACT DO OBSTETRIC COMPLICATIONS HAVE ON THE RISK OF ADVERSE PSYCHIATRIC OUTCOMES FOR THE HIGH RISK CHILDREN OF MOTHERS WITH SCHIZOPHRENIA AND OTHER PSYCHOSES? Schizophrenia Research. 102: 167-168. DOI: 10.1016/S0920-9964(08)70511-5  0.384
2008 Morgan K, Zubrick S, Bower C, Croft M, Valuri G, Jablensky A. WHY IS THE RISK OF INTELLECTUAL DISABILITY ELEVATED IN THE CHILDREN OF MOTHERS WITH SCHIZOPHRENIA AND OTHER PSYCHOSES? Schizophrenia Research. 102: 167. DOI: 10.1016/S0920-9964(08)70510-3  0.407
2008 Croft M, Green M, Morgan V, Valuri G, Jablensky A. THE HIGH RISK CHILDREN OF MOTHERS WITH SCHIZOPHRENIA AND OTHER SEVERE MENTAL ILLNESS: INSTRUMENTS FOR ASSESSING RISKS AND IDENTIFYING OUTCOMES Schizophrenia Research. 102: 164. DOI: 10.1016/S0920-9964(08)70499-7  0.401
2008 Waters F, Badcock J, Dragovic M, Jablensky A. FIRST-RANK SYMPTOMS IN SCHIZOPHRENIA: A COGNITIVE EXAMINATION OF THREE EXPLANATORY MODELS Schizophrenia Research. 102: 131. DOI: 10.1016/S0920-9964(08)70398-0  0.628
2008 Waters F, Price G, Jablensky A. INTERNAL MODEL DYSFUNCTION IN SCHIZOPHRENIA PATIENTS WITH FIRST-RANK SYMPTOMS: ELECTROPHYSIOLOGICAL EVIDENCE Schizophrenia Research. 102: 109. DOI: 10.1016/S0920-9964(08)70330-X  0.444
2008 Waters F, Badcock J, Dragovic M, Jablensky A. First rank symptoms in schizophrenia: A cognitive examination of three explanatory models European Psychiatry. 23: S153. DOI: 10.1016/J.Eurpsy.2008.01.913  0.662
2007 Owen MJ, Craddock N, Jablensky A. The genetic deconstruction of psychosis. Schizophrenia Bulletin. 33: 905-11. PMID 17551090 DOI: 10.1093/Schbul/Sbm053  0.478
2007 Morgan V, Zubrick S, Bower C, Croft M, Valuri G, Jablensky A. 2D-3 The neurodevelopmental hypothesis and schizophrenia. Evidence from the Western Australian study of women with severe mental illness Early Human Development. 83: S37. DOI: 10.1016/S0378-3782(07)70020-8  0.327
2006 Jablensky A, Hallmayer J, Dragovic M, Badcock J, Kalaydjieva L. 08-05 'Kraepelinian' and 'Bleulerian' schizophrenia: a genetic dissection of a cognitive endophenotype. Acta Neuropsychiatrica. 18: 332-3. PMID 27397392 DOI: 10.1017/S0924270800032336  0.666
2006 Dragovic M, Jablensky A. Converging evidence from taxometric analyses confirms a cognitive subtype of schizophrenia with distinct genetic basis. Acta Neuropsychiatrica. 18: 284-284. PMID 27397269 DOI: 10.1017/S0924270800031112  0.467
2006 Morgan V, Korten A, Jablensky A. Modifiable risk factors for hospitalization among people with psychosis: evidence from the National Study of Low Prevalence (Psychotic) Disorders. The Australian and New Zealand Journal of Psychiatry. 40: 683-90. PMID 16866764 DOI: 10.1111/J.1440-1614.2006.01868.X  0.323
2006 Jablensky A. Subtyping schizophrenia: implications for genetic research. Molecular Psychiatry. 11: 815-36. PMID 16801952 DOI: 10.1038/Sj.Mp.4001857  0.488
2006 Falkai P, Wobrock T, Lieberman J, Glenthoj B, Gattaz WF, Möller HJ, Altamura AC, Andreasen N, Barnes TRE, Beckmann H, Ciprian-Ollivier J, Crow T, David A, Davidson M, Deakin B, ... ... Jablensky A, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: Long-term treatment of schizophrenia World Journal of Biological Psychiatry. 7: 5-40. PMID 16509050 DOI: 10.1080/15622970500483177  0.304
2006 Price GW, Michie PT, Johnston J, Innes-Brown H, Kent A, Clissa P, Jablensky AV. A multivariate electrophysiological endophenotype, from a unitary cohort, shows greater research utility than any single feature in the Western Australian family study of schizophrenia. Biological Psychiatry. 60: 1-10. PMID 16368076 DOI: 10.1016/j.biopsych.2005.09.010  0.363
2005 Jablensky A. Boundaries of mental disorders. Current Opinion in Psychiatry. 18: 653-8. PMID 16639091 DOI: 10.1097/01.Yco.0000184412.98587.A4  0.306
2005 Jablensky A. The long and winding road of schizophrenia research. Epidemiologia E Psichiatria Sociale. 14: 179-83. PMID 16396424 DOI: 10.1017/S0924270800032518  0.388
2005 Falkai P, Wobrock T, Lieberman J, Glenthoj B, Gattaz WF, Möller HJ, Altamura AC, Andreasen N, Barnes TRE, Beckmann H, Ciprian-Ollivier J, Crow T, David A, Davidson M, Deakin B, ... ... Jablensky A, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: Acute treatment of schizophrenia World Journal of Biological Psychiatry. 6: 132-191. PMID 16173147 DOI: 10.1080/15622970510030090  0.322
2005 Jablensky A. Categories, dimensions and prototypes: critical issues for psychiatric classification. Psychopathology. 38: 201-5. PMID 16145275 DOI: 10.1159/000086092  0.331
2005 Dragovic M, Hammond G, Badcock JC, Jablensky A. Laterality phenotypes in patients with schizophrenia, their siblings and controls: associations with clinical and cognitive variables. The British Journal of Psychiatry : the Journal of Mental Science. 187: 221-8. PMID 16135858 DOI: 10.1192/Bjp.187.3.221  0.651
2005 Dragovic M, Hammond G, Jablensky A. Schizotypy and mixed-handedness revisited. Psychiatry Research. 136: 143-52. PMID 16112739 DOI: 10.1016/J.Psychres.2005.05.008  0.469
2005 Hallmayer JF, Kalaydjieva L, Badcock J, Dragovic M, Howell S, Michie PT, Rock D, Vile D, Williams R, Corder EH, Hollingsworth K, Jablensky A. Genetic evidence for a distinct subtype of schizophrenia characterized by pervasive cognitive deficit. American Journal of Human Genetics. 77: 468-76. PMID 16080121 DOI: 10.1086/432816  0.672
2005 Badcock JC, Dragović M, Waters FA, Jablensky A. Dimensions of intelligence in schizophrenia: evidence from patients with preserved, deteriorated and compromised intellect. Journal of Psychiatric Research. 39: 11-9. PMID 15504419 DOI: 10.1016/J.Jpsychires.2004.05.002  0.668
2005 Catts SV, Pantelis C, Dean B, Jablensky A. Schizophrenia research: Australia at the cutting edge Australian and New Zealand Journal of Psychiatry. 39. DOI: 10.1111/J.1440-1614.2005.01674_39_S1.X  0.446
2004 Kent AR, Fox AM, Michie PT, Jablensky AV. Differential impairment of working memory performance in first-degree relatives of individuals with schizophrenia. Acta Neuropsychiatrica. 16: 149-53. PMID 26984167 DOI: 10.1111/j.0924-2708.2004.00070.x  0.333
2004 Badcock JC, Williams RJ, Anderson M, Jablensky A. Speed of processing and individual differences in IQ in schizophrenia: General or specific cognitive deficits? Cognitive Neuropsychiatry. 9: 233-47. PMID 16571584 DOI: 10.1080/13546800344000228  0.689
2004 Jablensky A. Resolving schizophrenia's CATCH22. Nature Genetics. 36: 674-5. PMID 15226748 DOI: 10.1038/Ng0704-674  0.499
2004 Jablensky A. Researching psychiatry in Western Australia. The Australian and New Zealand Journal of Psychiatry. 38: 306-15. PMID 15144506 DOI: 10.1080/J.1440-1614.2004.01265.X  0.368
2004 Kavanagh DJ, Waghorn G, Jenner L, Chant DC, Carr V, Evans M, Hemnan H, Jablensky A, McGrath JJ. Demographic and clinical correlates of comorbid substance use disorders in psychosis: multivariate analyses from an epidemiological sample. Schizophrenia Research. 66: 115-24. PMID 15061243 DOI: 10.1016/S0920-9964(03)00130-0  0.334
2004 Kent AR, Fox AM, Michie PT, Jablensky AV. Differential impairment of working memory performance in first-degree relatives of individuals with schizophrenia Acta Neuropsychiatrica. 16: 149-153. DOI: 10.1111/j.0924-2708.2004.00070.x  0.302
2003 Todd J, Michie PT, Jablensky AV. Association between reduced duration mismatch negativity (MMN) and raised temporal discrimination thresholds in schizophrenia. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 114: 2061-70. PMID 14580604 DOI: 10.1016/S1388-2457(03)00246-3  0.339
2003 Hallmayer JF, Jablensky A, Michie P, Woodbury M, Salmon B, Combrinck J, Wichmann H, Rock D, D'Ercole M, Howell S, Dragović M, Kent A. Linkage analysis of candidate regions using a composite neurocognitive phenotype correlated with schizophrenia. Molecular Psychiatry. 8: 511-23. PMID 12808431 DOI: 10.1038/Sj.Mp.4001273  0.483
2003 Morgan V, Janca A, Jablensky A. Psychotic disorders in Australia: patients respond to national survey results. European Psychiatry : the Journal of the Association of European Psychiatrists. 18: 142. PMID 12763303 DOI: 10.1016/S0924-9338(03)00030-0  0.325
2003 Kendell R, Jablensky A. Distinguishing between the validity and utility of psychiatric diagnoses. The American Journal of Psychiatry. 160: 4-12. PMID 12505793 DOI: 10.1176/Appi.Ajp.160.1.4  0.312
2002 Michie PT, Innes-Brown H, Todd J, Jablensky AV. Duration mismatch negativity in biological relatives of patients with schizophrenia spectrum disorders. Biological Psychiatry. 52: 749-58. PMID 12372666 DOI: 10.1016/S0006-3223(02)01379-3  0.339
2002 Castle D, Morgan V, Jablensky A. Antipsychotic use in Australia: the patients' perspective. The Australian and New Zealand Journal of Psychiatry. 36: 633-41. PMID 12225447 DOI: 10.1046/J.1440-1614.2002.01037.X  0.362
2002 Jablensky A. The classification of personality disorders: critical review and need for rethinking. Psychopathology. 35: 112-6. PMID 12145494 DOI: 10.1159/000065129  0.3
2002 Gureje O, Herrman H, Harvey C, Morgan V, Jablensky A. The Australian National Survey of Psychotic Disorders: profile of psychosocial disability and its risk factors. Psychological Medicine. 32: 639-47. PMID 12102378 DOI: 10.1017/S0033291702005627  0.402
2002 Jablensky A. Research methods in psychiatric epidemiology: an overview. The Australian and New Zealand Journal of Psychiatry. 36: 297-310. PMID 12060178 DOI: 10.1046/J.1440-1614.2002.01035.X  0.326
2001 Gureje O, Herrman H, Harvey C, Trauer T, Jablensky A. Defining disability in psychosis: performance of the diagnostic interview for psychosis-disability module (DIP-DIS) in the Australian National Survey of Psychotic Disorders. The Australian and New Zealand Journal of Psychiatry. 35: 846-51. PMID 11990897 DOI: 10.1046/J.1440-1614.2001.00959.X  0.368
2001 Todd J, Michie PT, Jablensky AV. Do loudness cues contribute to duration mismatch negativity reduction in schizophrenia? Neuroreport. 12: 4069-73. PMID 11742240  0.306
2001 Morgan VA, Jablensky AV, Castle DJ. Season of birth in schizophrenia and affective psychoses in Western Australia 1916-61. Acta Psychiatrica Scandinavica. 104: 138-47. PMID 11473508 DOI: 10.1034/J.1600-0447.2001.00188.X  0.453
2001 Jablensky A. Classification of nonschizophrenic psychotic disorders: a historical perspective. Current Psychiatry Reports. 3: 326-31. PMID 11470040 DOI: 10.1007/S11920-001-0029-7  0.429
2001 Jablensky A, Lawrence D. Schizophrenia and cancer: is there a need to invoke a protective gene? Archives of General Psychiatry. 58: 579-80. PMID 11386987 DOI: 10.1001/Archpsyc.58.6.579  0.414
2000 Jablensky A. Epidemiology of schizophrenia: the global burden of disease and disability. European Archives of Psychiatry and Clinical Neuroscience. 250: 274-85. PMID 11153962 DOI: 10.1007/S004060070002  0.476
2000 Michie PT, Kent A, Stienstra R, Castine R, Johnston J, Dedman K, Wichmann H, Box J, Rock D, Rutherford E, Jablensky A. Phenotypic markers as risk factors in schizophrenia: neurocognitive functions. The Australian and New Zealand Journal of Psychiatry. 34: S74-85. PMID 11129319 DOI: 10.1080/000486700226  0.446
2000 Jablensky A. Prevalence and incidence of schizophrenia spectrum disorders: implications for prevention. The Australian and New Zealand Journal of Psychiatry. 34: S26-34; discussion S. PMID 11129313 DOI: 10.1080/000486700219  0.434
2000 Todd J, Michie PT, Budd TW, Rock D, Jablensky AV. Auditory sensory memory in schizophrenia: inadequate trace formation? Psychiatry Research. 96: 99-115. PMID 11063783 DOI: 10.1016/S0165-1781(00)00205-5  0.324
2000 Michie PT, Budd TW, Todd J, Rock D, Wichmann H, Box J, Jablensky AV. Duration and frequency mismatch negativity in schizophrenia. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 111: 1054-65. PMID 10825713 DOI: 10.1016/S1388-2457(00)00275-3  0.456
2000 Jablensky A, McGrath J, Herrman H, Castle D, Gureje O, Evans M, Carr V, Morgan V, Korten A, Harvey C. Psychotic disorders in urban areas: An overview of the Study on Low Prevalence Disorders Australian and New Zealand Journal of Psychiatry. 34: 221-236. PMID 10789527 DOI: 10.1080/J.1440-1614.2000.00728.X  0.332
2000 Jablensky A, McGrath J, Herrman H, Castle D, Gureje O, Carr V, Morgan V, Korten A, Harvey C. Psychotic disorders in urban Australia: A national study 1996–1998 Australian and New Zealand Journal of Psychiatry. 34: A32-A32. DOI: 10.1080/000486700646  0.33
2000 Jablensky A. What has epidemiology taught us about the nature of Schizophrenia? Australian and New Zealand Journal of Psychiatry. 34: A32-A32. DOI: 10.1080/000486700645  0.479
2000 Jablensky A, Michie P, Kent A. Familial risk for neurocognitive deficits associated with schizophrenia Schizophrenia Research. 41: 290. DOI: 10.1016/S0920-9964(00)91035-1  0.456
2000 Jablensky A, Herrman H, McGrath J, Evans M, Morgan V. Psychotic disorders in urban areas: Results from the Australian National Survey 1997–1998 Schizophrenia Research. 41: 65. DOI: 10.1016/S0920-9964(00)90444-4  0.349
2000 Jablensky A, Zubrick S, Morgan V, Bower C, Pinder T. The offspring of women with schizophrenia and affective psychoses: A population study Schizophrenia Research. 41: 8. DOI: 10.1016/S0920-9964(00)90324-4  0.423
2000 Irmansyah, Handoko HY, Heriani, Kusumawardhani A, Amir N, Wiwie NM, Widyawati I, Wibisono S, Salan R, Schwab SG, Hallmayer J, Jablensky A, Maier W, Wildenauer DB. Ascertainment of Indonesian families with schizophrenia for affected sib-pair analysis American Journal of Medical Genetics - Neuropsychiatric Genetics. 96: 504.  0.336
1999 Jablensky A. The concept of schizophrenia: Pro et contra Epidemiologia E Psichiatria Sociale. 8: 242-247. PMID 10709314 DOI: 10.1017/S1121189X00008149  0.44
1999 Farmer A, Kendler KS, Jablensky A, Crow TJ, Johnstone E. Invited commentaries on: People at risk of schizophrenia British Journal of Psychiatry. 174: 554-557. PMID 10616635  0.349
1999 Jablensky A. The conflict of the nosologists: Views on schizophrenia and manic-depressive illness in the early part of the 20th century Schizophrenia Research. 39: 95-100. PMID 10507518 DOI: 10.1016/S0920-9964(99)00106-1  0.474
1999 Jablensky A. Schizophrenia: Epidemiology Current Opinion in Psychiatry. 12: 19-28. DOI: 10.1097/00001504-199901000-00013  0.381
1999 Jablensky A. Psychiatric Epidemiology and the Global Public Health Agenda International Journal of Mental Health. 28: 6-14. DOI: 10.1080/00207411.1999.11449450  0.353
1998 Souery D, Lipp O, Serretti A, Mahieu B, Rivelli SK, Cavallini C, Ackenheil M, Adolfsson R, Aschauer H, Blackwood D, Dam H, Delcoigne B, Demartelaer V, Dikeos D, Fuchshuber S, ... ... Jablensky A, et al. European Collaborative Project on Affective Disorders: Interactions between genetic and psychosocial vulnerability factors Psychiatric Genetics. 8: 197-205. PMID 9861637 DOI: 10.1097/00041444-199808040-00001  0.309
1998 Jablensky A, Zubrick S, Morgan V, Bower C, Yellachich L, Nguyen H, Pinder T, Montgomery P, Croft M, Castle D. Reproductive pathology in women with schizophrenia and affective psychoses Schizophrenia Research. 29: 20. DOI: 10.1016/S0920-9964(97)88338-7  0.425
1998 Morgan V, Castle D, Page A, Montgomery P, Gurrin L, Burton P, Fazio S, Jablensky A. Influenza epidemics and the incidence of schizophrenia, affective disorders and mental retardation: Further data from Western Australia Schizophrenia Research. 29: 18. DOI: 10.1016/S0920-9964(97)88333-8  0.457
1997 Jablensky A. The 100-year epidemiology of schizophrenia Schizophrenia Research. 28: 111-125. PMID 9468347 DOI: 10.1016/S0920-9964(97)85354-6  0.488
1997 Morgan V, Castle D, Page A, Fazio S, Gurrin L, Burton P, Montgomery P, Jablensky A. Influenza epidemics and incidence of schizophrenia, affective disorders and mental retardation in Western Australia: No evidence of a major effect Schizophrenia Research. 26: 25-39. PMID 9376335 DOI: 10.1016/S0920-9964(97)00033-9  0.433
1997 Jablensky A, Cole SW. Is the earlier age at onset of schizophrenia in males a confounded finding? Results from a cross-cultural investigation British Journal of Psychiatry. 170: 234-240. PMID 9229029 DOI: 10.1192/Bjp.170.3.234  0.43
1997 Jablensky A, Yellachich L, Zubrick S, Morgan V, Bower C, Nguyen H, Fazio S, Montgomery P, Castle D. Reproductive pathology in women with schizophrenia and bipolar affective disorder: An epidemiological and clinical study Schizophrenia Research. 24: 252. DOI: 10.1016/S0920-9964(97)82724-7  0.443
1996 Jablensky A, Cole SW. Is the earlier age at onset of schizophrenia in males a confounded finding Schizophrenia Research. 18: 111. DOI: 10.1016/0920-9964(96)85383-7  0.437
1995 Jablensky A. Schizophrenia: Recent epidemiologic issues Epidemiologic Reviews. 17: 10-20. PMID 8521927 DOI: 10.1093/Oxfordjournals.Epirev.A036164  0.479
1995 Castle D, Golich Z, Rouse H, Jablensky A. The changing incidence of schizophrenia: Nature of the secular trend Schizophrenia Research. 15: 190-191. DOI: 10.1016/0920-9964(95)95586-X  0.336
1994 Manton KG, Korten A, Woodbury MA, Anker M, Jablensky A. Symptom profiles of psychiatric disorders based on graded disease classes: an illustration using data from the WHO International Pilot Study of Schizophrenia. Psychological Medicine. 24: 133-44. PMID 8208878  0.307
1994 Jablensky A, Sartorius N, Cooper JE, Anker M, Korten A, Bertelsen A. Culture and schizophrenia. Criticisms of WHO studies are answered British Journal of Psychiatry. 165: 434-436. PMID 7804655 DOI: 10.1192/Bjp.165.4.434  0.446
1994 Jablensky A. Discussion of B.P. Dhorenwend: 'Psychology, psychologists and psychiatric epidemiology' Acta Psychiatrica Scandinavica, Supplement. 90: 23-24. DOI: 10.1111/J.1600-0447.1994.Tb05910.X  0.325
1993 Jablensky A, Hugler H, Von Cranach M, Kalinov K. Kraepelin revisited: A reassessment and statistical analysis of dementia praecox and manic-depressive insanity in 1908 Psychological Medicine. 23: 843-858. PMID 8134510 DOI: 10.1017/S0033291700026337  0.332
1993 Jablensky A. The epidemiology of schizophrenia Current Opinion in Psychiatry. 6: 43-52. DOI: 10.1111/J.1440-1614.2006.01832.X  0.481
1992 Leff J, Sartorius N, Jablensky A, Korten A, Ernberg G. The International Pilot Study of schizophrenia: Five-year follow-up findings Psychological Medicine. 22: 131-145. PMID 1574549 DOI: 10.1017/S0033291700032797  0.406
1992 Jablensky A, Sartorius N, Ernberg G, Anker M, Korten A, Cooper JE, Day R, Bertelsen A. Schizophrenia manifestations, incidence and course in different cultures. A World Health Organization ten-country study Psychological Medicine. 22: 1-97. PMID 1565705 DOI: 10.1017/S0264180100000904  0.402
1990 Leff J, Wig NN, Bedi H, Menon DK, Kuipers L, Korten A, Ernberg G, Day R, Sartorius N, Jablensky A. Relatives' expressed emotion and the course of schizophrenia in Chandigarh. A two-year follow-up of a first-contact sample British Journal of Psychiatry. 156: 351-356. PMID 2346833 DOI: 10.1192/Bjp.156.3.351  0.369
1989 Jablensky A. Epidemiology and Cross-Cultural Aspects of Schizophrenia Psychiatric Annals. 19: 516-524. DOI: 10.3928/0048-5713-19891001-05  0.432
1988 Jablensky A, Sartorius N, Korten A, Ernberg G, Anker M, Cooper JE, Day R. Incidence worldwide of schizophrenia. The British Journal of Psychiatry : the Journal of Mental Science. 151: 408-9. PMID 3427300 DOI: 10.1192/S0007125000216802  0.472
1988 Katz MM, Marsella A, Dube KC, Olatawura M, Takahashi R, Nakane Y, Wynne LC, Gift T, Brennan J, Sartorius N, Jablensky A. On the expression of psychosis in different cultures: Schizophrenia in an indian and in a Nigerian community - A Report from the World Health Organization Project on Determinants of Outcome of Severe Mental Disorders Culture, Medicine and Psychiatry. 12: 331-355. PMID 3234016 DOI: 10.1007/Bf00051973  0.424
1988 Jablensky A, Sartorius N. Is schizophrenia universal? Acta Psychiatrica Scandinavica, Supplement. 344: 65-70. PMID 3067530 DOI: 10.1111/J.1600-0447.1988.Tb09003.X  0.482
1987 Day R, Nielsen JA, Korten A, Ernberg G, Dube KC, Gebhart J, Jablensky A, Leon C, Marsella A, Olatawura M. Stressful life events preceding the acute onset of schizophrenia: a cross-national study from the World Health Organization. Culture, Medicine and Psychiatry. 11: 123-205. PMID 3595169 DOI: 10.1007/Bf00122563  0.406
1987 Sartorius N, Jablensky A, Korten A, Ernberg G, Anker M, Cooper JE, Day R. Early manifestations and first-contact incidence of schizophrenia in different cultures. A preliminary report on the initial evaluation phase of the WHO Collaborative Study on determinants of outcome of severe mental disorders. Psychological Medicine. 16: 909-28. PMID 3493497 DOI: 10.1017/S0033291700011910  0.47
1987 Jablensky A. Multicultural Studies and the Nature of Schizophrenia: A Review Journal of the Royal Society of Medicine. 80: 162-167. DOI: 10.1177/014107688708000313  0.46
1986 Jablensky A. Epidemiology of schizophrenia: a European perspective. Schizophrenia Bulletin. 12: 52-73. PMID 3961427 DOI: 10.1093/Schbul/12.1.52  0.512
1985 Jablensky A. Epidemiological and clinical research as a guide in the search for risk factors and biological markers. Journal of Psychiatric Research. 18: 541-56. PMID 6392529 DOI: 10.1016/0022-3956(84)90039-6  0.483
1980 Jablensky A, Schwarz R, Tomov T. WHO collaborative study on impairments and disabilities associated with schizophrenic disorders Acta Psychiatrica Scandinavica. 62: 152-163. DOI: 10.1111/J.1600-0447.1980.Tb07687.X  0.417
1979 Sartorius N, Jablensky A, Shapiro R. Cross-cultural differences in the short-term prognosis of schizophrenic psychoses. Schizophrenia Bulletin. 4: 102-13. PMID 746359 DOI: 10.1093/Schbul/4.1.102  0.361
1978 Sheldrick C, Jablensky A, Sartorius N, Shepherd M. Schizophrenia succeeded by affective illness; catamnestic study and statistical enquiry. Psychological Medicine. 7: 619-24. PMID 594242 DOI: 10.1017/S0033291700006267  0.496
1977 Sartorius N, Jablensky A, Shapiro R. Two-year follow-up of the patients included in the WHO International Pilot Study of Schizophrenia. Psychological Medicine. 7: 529-41. PMID 905470 DOI: 10.1017/S0033291700004517  0.302
1975 Jablensky A, Sartorius N. Culture and schizophrenia. Psychological Medicine. 5: 113-24. PMID 1161950 DOI: 10.1017/S003329170005635X  0.44
1974 Sartorius N, Shapiro R, Jablensky A. The International Pilot Study of Schizophrenia Schizophrenia Bulletin. 1: 21-34. PMID 4619919 DOI: 10.1093/Schbul/1.11.21  0.484
Show low-probability matches.